Abstract | INTRODUCTION: There are controversies over the long-term persistence of post vaccination immunity to hepatitis B and the need for booster doses of the vaccine. The aim of this study was to verify antibody levels of antibody against hepatitis B virus surface antigen (anti-HBs) in children aged 1 to 15 years who received vaccination against hepatitis B in the central province of Iran, Semnan. MATERIALS AND METHODS: We performed a seroepidemiological survey (n = 210) of anti-HBs in 2011 in the central province of Iran, Semnan using enzyme-linked immunosorbent assay (ELISA). The levels of anti-HBs < 10 mIU/mL were considered to be negative and samples showing an anti-HBs titer ≥ 10 mIU/mL was considered protective. RESULTS: Protective antibody levels were detected in 88% of the children less than 5 year after vaccination, decreased to 78% between 5 to 10 years after vaccination, and further declined to 74% in 10 years after vaccination, respectively. CONCLUSION: The vaccination program has been proven effective in Semnan and immunological protection against hepatitis B infection was found in the majority of children even more than 10 years after being vaccinated.
|
Authors | M Rezaei, S Nooripoor, R Ghorbani, F Ramezanshams, S Mamishi, S Mahmoudi |
Journal | Journal of preventive medicine and hygiene
(J Prev Med Hyg)
Vol. 55
Issue 1
Pg. 1-3
(Mar 2014)
ISSN: 1121-2233 [Print] Italy |
PMID | 25916024
(Publication Type: Journal Article)
|
Chemical References |
- Hepatitis B Antibodies
- Hepatitis B Surface Antigens
- Hepatitis B Vaccines
|
Topics |
- Adolescent
- Child
- Child, Preschool
- Cross-Sectional Studies
- Enzyme-Linked Immunosorbent Assay
- Female
- Hepatitis B
(immunology, prevention & control)
- Hepatitis B Antibodies
(immunology)
- Hepatitis B Surface Antigens
(immunology)
- Hepatitis B Vaccines
(immunology, therapeutic use)
- Hepatitis B virus
(immunology)
- Humans
- Infant
- Iran
- Male
- Time Factors
|